BDSA forecasts re-scheduling will have profound implications not only for the cannabis industry but also for the broader economy

Last week, the DEA announced its decision to reschedule cannabis to Schedule III under the Controlled Substances Act. This decision marks a historic step toward the end of cannabis prohibition, acknowledging its medical benefits and lifting the unfair burden on cannabis businesses. BDSA forecasts this regulatory change will have profound implications not only for the cannabis […]